South San Francisco, CA, United States of America

Jia Wu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jia Wu in Antibody Development

Introduction

Jia Wu is an accomplished inventor based in South San Francisco, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of isoform-selective anti-TGFβ antibodies. Her work is crucial for advancing treatments for various TGFβ-related disorders.

Latest Patents

Jia Wu holds a patent for "Isoform-selective anti-TGFβ antibodies and methods of use." This invention provides isoform-selective anti-TGFβ antibodies, including anti-TGFβ2, anti-TGFβ3, and anti-TGFβ2/3 monoclonal antibodies. These antibodies are particularly useful for the treatment of fibrosis and other disorders related to TGFβ.

Career Highlights

Jia Wu is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative therapies. Her work at Genentech has allowed her to focus on groundbreaking research and development in the field of antibody therapies.

Collaborations

Jia Wu collaborates with notable colleagues, including Wei-Ching Liang and Joseph R Arron. These partnerships enhance her research efforts and contribute to the advancement of therapeutic solutions.

Conclusion

Jia Wu's innovative work in the development of isoform-selective anti-TGFβ antibodies represents a significant advancement in biotechnology. Her contributions are paving the way for new treatments for TGFβ-related disorders, showcasing her impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…